{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:09:05Z","timestamp":1781215745865,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,8,29]],"date-time":"2001-08-29T00:00:00Z","timestamp":999043200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/1471-230x-1-8","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:40:44Z","timestamp":1034361644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis"],"prefix":"10.1186","volume":"1","author":[{"given":"Leonard G","family":"Quallich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Greenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M","family":"Haftel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,8,29]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7326\/0003-4819-101-3-377","volume":"3","author":"MA Peppercorn","year":"1984","unstructured":"Peppercorn MA: Sulphasalazine pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med. 1984, 3: 377-386.","journal-title":"Ann Intern Med"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(21)00421-0","volume":"18","author":"KM Das","year":"1989","unstructured":"Das KM: Sulphasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Amer. 1989, 18: 1-20.","journal-title":"Gastroenterol Clin North Amer"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/gut.5.5.437","volume":"5","author":"AP Dick","year":"1964","unstructured":"Dick AP, Grayson MJ, Carpenter RG, Petrie A: Controlled trial of sulfasalazine in the treatment of ulcerative colitis. Gut. 1964, 5: 437-432.","journal-title":"Gut"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/art.1780380507","volume":"38","author":"M Dougados","year":"1995","unstructured":"Dougados M, Van der Linden S, Leirisalo-Repo M, et al: Sulfasalazine in the treatment of sponyloarthropathy: a randomized, multi-center, double-blinded, placebo-controlled study. Arthritis Rheum. 1995, 38: 618-627.","journal-title":"Arthritis Rheum"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/art.1780291202","volume":"29","author":"RS Pinals","year":"1986","unstructured":"Pinals RS, Kaplan SB, Lawson JG, Hepburn B: Sulfasalazine in rheumatoid arthritis. Arthritis Rheum. 1986, 29: 1427-1434.","journal-title":"Arthritis Rheum"},{"key":"8_CR6","first-page":"360","volume":"23","author":"LF Imundo","year":"1996","unstructured":"Imundo LF, Jacobs JC: Sulfasalazine therapy for juvenile rheumatoid arthritis. J Rheumatol. 1996, 23: 360-366.","journal-title":"J Rheumatol"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.2","volume":"34","author":"RS Amos","year":"1995","unstructured":"Amos RS: The history of the use of sulphasalazine in rheumatology. Br J Rheumatol. 1995, 34: 2-6.","journal-title":"Br J Rheumatol"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.40","volume":"34","author":"PLCM Van Riel","year":"1995","unstructured":"Van Riel PLCM, Van Gestel AM, Van De Putte LBA: Long-term usage and side effect profile of sulphasalazine in rheumatoid arthritis. Br J Rheumatol. 1995, 34: 40-42.","journal-title":"Br J Rheumatol"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bmj.293.6544.420","volume":"293","author":"RS Amos","year":"1986","unstructured":"Amos RS, Pullar TT, Bax DE, et al: Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed). 1986, 293: 420-423.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/ard.46.3.177","volume":"46","author":"RD Situnayake","year":"1987","unstructured":"Situnayake RD, Grindulis KA, McConkey B: Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis. 1987, 46: 177-183.","journal-title":"Ann Rheum Dis"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02349638","volume":"30","author":"H Nakajima","year":"1995","unstructured":"Nakajima H, Munakata A, Yoshida : Adverse effects of sulfasalazine and the treatment of ulcerative colitis with mesalazine. J Gastroenterol. 1995, 30: 115-117.","journal-title":"J Gastroenterol"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/art.1780390503","volume":"39","author":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines","year":"1996","unstructured":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 723-731.","journal-title":"Arthritis Rheum"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/03009749409099284","volume":"23","author":"K Laasila","year":"1994","unstructured":"Laasila K, Leirisalo-Repo M: Side effects of sulphasalazine in patients with rheumatic diseases of inflammatory bowel disease. Scand J Rheumatol. 1994, 23: 338-340.","journal-title":"Scand J Rheumatol"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-198600321-00003","volume":"32","author":"G Watkinson","year":"1986","unstructured":"Watkinson G: Sulphasalazine: A review of 40 years' experience. Drugs. 1986, 32: 1-11.","journal-title":"Drugs"},{"key":"8_CR15","first-page":"1071","volume":"135","author":"JD Losek","year":"1981","unstructured":"Losek JD, Werlin SL: Sulfasalazine hepatotoxicity. Am J Dis Child. 1981, 135: 1071-1072.","journal-title":"Am J Dis Child"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1056\/NEJM196710122771503","volume":"277","author":"C Dujovne","year":"1967","unstructured":"Dujovne C, Chan C, Zimmerman J: Sulfonamide hepatic injury. N Engl J Med. 1967, 277: 785-788.","journal-title":"N Engl J Med"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF02283121","volume":"11","author":"H Brooks","year":"1992","unstructured":"Brooks H, Taylor H, Nichol F: The three week sulphasalazine syndrome. Clin Rheum. 1992, 11: 566-568.","journal-title":"Clin Rheum"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF01255610","volume":"19","author":"R Rafoth","year":"1974","unstructured":"Rafoth R: Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease. Dig Diseases. 1974, 19: 465-469.","journal-title":"Dig Diseases"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0272-6386(88)80144-6","volume":"11","author":"DR Singer","year":"1988","unstructured":"Singer DR, Simpson JG, Catto GR, Johnston AW: Drug hypersensitivity causing granulomatous interstitial hepatitis. Am J Kid Dis. 1988, 11: 357-359.","journal-title":"Am J Kid Dis"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/archinte.1980.00330150109025","volume":"140","author":"DA Bramlet","year":"1980","unstructured":"Bramlet DA, Posalaky Z, Olson R: Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Arch Intern Med. 1980, 140: 395-397. 10.1001\/archinte.140.3.395.","journal-title":"Arch Intern Med"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2169\/internalmedicine.34.89","volume":"34","author":"A Takami","year":"1995","unstructured":"Takami A, Nakao S, Miyamori H, et al: Adult Onset Still's disease with submassive hepatic necrosis. Internal Medicine. 1995, 34: 89-91.","journal-title":"Internal Medicine"},{"key":"8_CR22","first-page":"401","volume":"79","author":"A Fich","year":"1984","unstructured":"Fich A, Schwartz J, Braverman D, Zifroni A, Rachmilewitz D: Sulfasalazine hepatotoxicity. Am J Gastroenterol. 1984, 79: 401-402.","journal-title":"Am J Gastroenterol"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00004836-198106000-00017","volume":"3","author":"A Namias","year":"1981","unstructured":"Namias A, Bhalotra R, Donowitz M: Reversible sulfasalazine-induced granulomatous hepatitis. J Clin Gastroenterol. 1981, 3: 193-198.","journal-title":"J Clin Gastroenterol"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/00007611-197809000-00031","volume":"71","author":"J Callen","year":"1978","unstructured":"Callen J, Soderstrom : Granulomatous hepatitis associated with salicylazosulfapyridine therapy. S Med Journal. 1978, 71: 1159-1160.","journal-title":"S Med Journal"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF01451021","volume":"17","author":"JL Huang","year":"1998","unstructured":"Huang JL, Hung I, Chen LC, Lee WY, Hsueh C, Hsieh KH: Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin. Clin Rheumatol. 1998, 17: 349-352.","journal-title":"Clin Rheumatol"},{"key":"8_CR26","first-page":"789","volume":"89","author":"R Rubin","year":"1994","unstructured":"Rubin R: Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol. 1994, 89: 789-791.","journal-title":"Am J Gastroenterol"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00004836-199203000-00012","volume":"14","author":"G Marinos","year":"1992","unstructured":"Marinos G, Riley J, Painter D, McCaughan G: Sulfasalazine-induced fulminant hepatic failure. J Clin Gastroenterol. 1992, 14: 132-135.","journal-title":"J Clin Gastroenterol"},{"key":"8_CR28","first-page":"205","volume":"81","author":"J Ribe","year":"1986","unstructured":"Ribe J, Benkov K, Thung S, Shen S, LeLeiko N: Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine. Am J Gastroenterol. 1986, 81: 205-208.","journal-title":"Am J Gastroenterol"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/BF01072475","volume":"23","author":"RS Kanner","year":"1978","unstructured":"Kanner RS, Tedesco FJ, Kalser MH: Azulfidine (sulfasalazine) induced hepatic injury. Am J Dig Dis. 1978, 23: 956-8.","journal-title":"Am J Dig Dis"},{"key":"8_CR30","first-page":"561","volume":"72","author":"RM Gulley","year":"1979","unstructured":"Gulley RM, Mirza A, Kelley CE: Hepatotoxicity of salicylazosulfapyridine: A case report and review of the literature. Am J Gastroenterol. 1979, 72: 561-564.","journal-title":"Am J Gastroenterol"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1445-5994.1982.tb02433.x","volume":"12","author":"MD Smith","year":"1982","unstructured":"Smith MD, Gibson GE, Rowland R: Combined hepatotoxicity and neurotoxicity following sulfasalazine administration. Aust N Z J Med. 1982, 12: 76-80.","journal-title":"Aust N Z J Med"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","volume":"105","author":"NH Shear","year":"1986","unstructured":"Shear NH, Spielberg SP, Grany DM, et al: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986, 105: 179-184.","journal-title":"Ann Intern Med"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/clpt.1991.3","volume":"49","author":"MJ Rieder","year":"1991","unstructured":"Rieder MJ, Shear NH, Kanee A, et al: Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharm Ther. 1991, 49: 13-17.","journal-title":"Clin Pharm Ther"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02333012","volume":"43","author":"M Keisu","year":"1992","unstructured":"Keisu M, Ekman E: Sulfasalazine associated agranulocytosis in Sweden 1972\u20131989. Eur J Clin Pharmacol. 1992, 43: 215-218.","journal-title":"Eur J Clin Pharmacol"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/014107688007300811","volume":"73","author":"JL Maddocks","year":"1980","unstructured":"Maddocks JL, Slater DN: Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulfasalazine. J R Soc Med. 1980, 73: 587-588.","journal-title":"J R Soc Med"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0016-5085(19)35345-4","volume":"37","author":"DA Roth","year":"1959","unstructured":"Roth DA, Lindert M: A fatal case of Azulfidine-induced agranulocytosis. Gastroenterology. 1959, 37: 787-789.","journal-title":"Gastroenterology"},{"key":"8_CR37","first-page":"118","volume":"80","author":"IM Jacobson","year":"1985","unstructured":"Jacobson IM, Kelsey PB, Blyden GT, et al: Sulfasalazine induced agranulocytosis. Am J Gastroenterol. 1985, 80: 118-121.","journal-title":"Am J Gastroenterol"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/j.1875-9114.1995.tb04352.x","volume":"15","author":"H Jick","year":"1995","unstructured":"Jick H, Myers MW, Dean AD: The risk of sulfasalazine and mesalazine-assoicated blood disorders. Pharmacotherapy. 1995, 15: 176-181.","journal-title":"Pharmacotherapy"},{"key":"8_CR39","first-page":"621","volume":"19","author":"E Kuipers","year":"1992","unstructured":"Kuipers E, Vellenga E, Joost T, Hazenberg B: Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. J Rheumatol. 1992, 19: 621-622.","journal-title":"J Rheumatol"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1365-2036.1995.tb00443.x","volume":"9","author":"P Roddie","year":"1995","unstructured":"Roddie P, Dorrance H, Cook M, Rainey J: Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor. Aliment Pharm Ther. 1995, 9: 711-712.","journal-title":"Aliment Pharm Ther"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s002960050012","volume":"17","author":"T Senturk","year":"1997","unstructured":"Senturk T, Aydintug A, Duzgun N, Tokgoz G: Seizures and hepatotoxicity following sulphasalazine administration. Rheumatol Int. 1997, 17: 75-77. 10.1007\/s002960050012.","journal-title":"Rheumatol Int"},{"key":"8_CR42","first-page":"748","volume":"21","author":"ME Hill","year":"1994","unstructured":"Hill ME, Gordon C, Situnayake RD, Heath DA: Sulfasalazine induced seizures and dysphagia. J Rheumatol. 1994, 21: 748-749.","journal-title":"J Rheumatol"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/archneur.1991.00530200084023","volume":"48","author":"A Krumholz","year":"1991","unstructured":"Krumholz A, Stern BJ, Stern EG: Clinical implications of seizures in neurosarcoidosis. Arch Neurol. 1991, 48: 842-844.","journal-title":"Arch Neurol"},{"key":"8_CR44","first-page":"457","volume":"56","author":"B Pentland","year":"1985","unstructured":"Pentland B, Mitchell JD, Cull RE, Ford MJ: Central nervous system sarcoidosis. QJM. 1985, 56: 457-465.","journal-title":"QJM"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/archderm.1995.01690170046006","volume":"131","author":"P Wolkenstein","year":"1995","unstructured":"Wolkenstein P, Charue D, Laurent P, et al: Metabolic predisposition to cutaneous adverse drug reactions: Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Derm. 1995, 131: 544-551. 10.1001\/archderm.131.5.544.","journal-title":"Arch Derm"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-1-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-1-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-1-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-1-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:05:51Z","timestamp":1726239951000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-1-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-1-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,29]]},"assertion":[{"value":"30 July 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}